Welcome to our dedicated page for Algorhythm Holdings SEC filings (Ticker: RIME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Algorhythm Holdings, Inc. (NASDAQ: RIME) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including Forms 10-K, 10-Q, 8-K, proxy statements, and registration statements. Algorhythm is a smaller reporting company that has transitioned into an AI logistics and distribution business centered on SemiCab, and its filings provide detailed insight into this transformation, its capital structure, and its risk profile.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review Algorhythm’s financial statements, segment information related to SemiCab, and discussions of material weaknesses, liquidity, and operating performance. Current reports on Form 8-K document key events such as the sale of the legacy Singing Machine karaoke business, the acquisition of SMCB Solutions Private Limited to expand SemiCab in India, the launch of the Apex SaaS platform, changes in independent registered public accounting firms, director and officer appointments and resignations, and stockholder votes on matters like reverse stock split authority, reincorporation, and equity incentive plan amendments.
Registration statements on Form S-1 and S-1/A describe Algorhythm’s arrangements with investors such as Streeterville Capital, LLC, including pre-paid purchase structures, commitment shares, and resale registration for common stock and warrants. These documents outline potential dilution, use of proceeds, and the company’s status as a smaller reporting company. Proxy materials on Schedule 14A provide additional context on corporate governance, board composition, and stockholder proposals.
On Stock Titan, Algorhythm’s filings are supplemented with AI-powered summaries that explain the significance of lengthy documents, highlight major changes from prior periods, and flag items that may affect shareholders, such as financing terms, auditor changes, and governance actions. Real-time updates from EDGAR ensure that new 8-Ks, 10-Qs, and 10-Ks appear promptly, while Form 4 insider transaction reports, when filed, can help users track equity awards and share activity by directors and officers. By using these tools, investors can navigate Algorhythm’s evolving AI logistics strategy, capital markets activity, and compliance record without reading every line of each filing.
Algorhythm Holdings, Inc. entered into a new secured pre-paid equity financing with Streeterville Capital, labeled Secured Pre-Paid Purchase #4. This fourth pre-paid purchase has a principal amount of $10,355,000, carries 9% annual interest and a three-year maturity.
The company received $9,500,000 in proceeds, of which $3,500,000 was placed into a controlled deposit account that secures the obligation, subject to a minimum balance formula tied to the outstanding principal. A wholly owned subsidiary, RIME Holdings, LLC, provided a guaranty. Univest Securities, LLC earns cash fees equal to 8% of the funds released to the company outside the secured account.
L1 Capital Global Opportunities Master Fund, Ltd. filed an amended Schedule 13G reporting its beneficial ownership in Algorhythm Holdings, Inc. common stock. The fund reports beneficial ownership of 142,905 securities, including 142,905 warrants to purchase common shares, with sole voting and dispositive power over this amount.
This position represents 4.99% of Algorhythm’s common stock, based on 2,721,778 shares outstanding as of November 17, 2025, as disclosed in the company’s Form 10-Q. An additional 140,507 warrants are not counted because they are subject to a 4.99% beneficial ownership limitation.
David Feldman and Joel Arber, as directors of the fund, may be deemed to beneficially own these securities under SEC rules, but both expressly disclaim beneficial ownership for all other purposes. The filing also certifies that the securities are not held to change or influence control of Algorhythm.
Algorhythm Holdings, Inc. reported that it has 5,758,102 shares of common stock, par value $0.01 per share, issued and outstanding as of January 21, 2026. This update gives investors an official share count, which is an important baseline figure for understanding the company’s market value and ownership structure.
Algorhythm Holdings, Inc. (RIME) reported results of its 2025 annual stockholder meeting. Stockholders representing 1,194,491 shares, or 45.2% of the common stock outstanding and eligible to vote, were present in person or by proxy, constituting a quorum.
All seven director nominees were elected. Stockholders approved authorizing the board to implement a reverse stock split at a ratio between 1-for-2 and 1-for-10 within one year of November 20, 2025, and approved reincorporation of the company from Delaware to Nevada by conversion.
They also approved increasing the shares authorized under the 2022 Equity Incentive Plan to 5,000,000, and approved the potential issuance of common stock to Streeterville Capital, LLC in pre-paid financing transactions that may collectively equal or exceed 20% of the company’s issued and outstanding common stock. In addition, stockholders ratified M&K CPAs as auditor for the fiscal year ending December 31, 2025 and approved the ability to adjourn the meeting to solicit additional proxies on key proposals.
Algorhythm Holdings, Inc. (RIME) is now a pure-play AI logistics company but remains under severe financial pressure. The company sold its legacy Singing Machine karaoke business on August 1, 2025 for $500,000, which is reported as a discontinued operation, and now operates solely through its SemiCab AI-enabled logistics platform.
From continuing operations, net sales for the nine months ended September 30, 2025 rose to $3,018,000 from $127,000 a year earlier, yet the business still generated a gross loss of $698,000 and a loss from continuing operations of $10,713,000. Including discontinued operations, net loss was $13,085,000 versus $7,513,000 in the prior-year period.
Cash declined to $2,839,000 at September 30, 2025 from $7,233,000 at December 31, 2024, and management states there is substantial doubt about the company’s ability to continue as a going concern without additional financing. To fund operations, Algorhythm entered into multiple high-cost debt and structured equity arrangements, including a secured prepaid share purchase with Streeterville Capital and several short-term notes. Shares outstanding were 2,721,778 as of November 17, 2025 after a 1-for-200 reverse stock split and warrant-driven share issuances.
Algorhythm Holdings, Inc. (RIME) filed a current report announcing that it released a press release with its financial results for the third quarter ended September 30, 2025, furnished as Exhibit 99.1. The company also reported that, effective November 14, 2025, board member Jay B. Foreman resigned from the Board of Directors and from the audit, compensation, nominating and corporate governance, and executive committees. The company stated that his resignation was not due to any disagreement with the company on its operations, policies, or practices.
Algorhythm Holdings (RIME) filed a prospectus to offer up to 1,133,652 shares of common stock issuable upon exercise of outstanding Series A warrants. The warrants have a cash exercise price of $8.38 per share, are currently exercisable, and expire on January 13, 2030. In the event all Series A warrants are exercised for cash, the company would receive approximately $9,500,000 in proceeds.
Shares outstanding were 2,641,778 as of September 29, 2025. Assuming full exercise of the Series A warrants, shares outstanding would be 3,775,430. The company’s common stock trades on Nasdaq as “RIME,” and the last reported sale price was $2.048 per share on November 7, 2025. The prospectus highlights risks including potential dilution from warrant exercises and going concern uncertainty noted in the auditor’s report for the year ended December 31, 2024.
Algorhythm Holdings, Inc. (RIME) filed a prospectus to register the resale of up to 10,095,694 shares of common stock by Streeterville Capital, LLC. The registered shares include 95,694 commitment shares already issued and up to 10,000,000 additional shares that may be issued under a pre‑paid purchase facility. The company will not receive any proceeds from Streeterville’s resale of these shares.
Under the Securities Purchase Agreement, Algorhythm may conduct one or more pre‑paid purchases for an aggregate purchase price of up to $20,000,000. Streeterville may, at its discretion, acquire shares against outstanding balances at a purchase price equal to 90% of the lowest 10‑day VWAP, subject to a floor price defined as the greater of 20% of the Nasdaq “Minimum Price” or $0.10, a 9.99% beneficial ownership cap, and Nasdaq Listing Rule 5635(d) limits unless shareholder approval is obtained. The plan of distribution permits sales via brokers, private transactions, or dealer transactions.
Shares outstanding were 2,641,778 as of September 29, 2025; the table shows up to 12,641,778 shares outstanding after the offering. The prospectus highlights risks including potential dilution and selling pressure from resales, and discloses prior losses and an auditor’s going‑concern explanatory paragraph for the year ended December 31, 2024.
Algorhythm Holdings, Inc. (RIME) filed Amendment No. 1 to Form S-1 with two prospectuses: a resale and a public offering. The resale prospectus registers up to 10,095,694 shares of common stock for Streeterville Capital, LLC, including 95,694 Commitment Shares and up to 10,000,000 shares issuable under a Securities Purchase Agreement. We will not receive any proceeds from Streeterville’s sales.
The public offering prospectus covers up to 1,133,652 shares issuable upon exercise of outstanding Series A warrants at an exercise price of $8.38 per share, expiring January 13, 2030.
The Streeterville facility permits Pre-Paid Purchases for an aggregate up to $20,000,000, including an initial $4,390,000 secured pre-paid purchase accruing 9% interest with a three-year maturity. Issuances are subject to a 9.99% beneficial ownership cap and Nasdaq Listing Rule 5635(d) limits. Common stock outstanding was 2,641,778 shares as of September 29, 2025 and, if all registered resale shares are issued, could be up to 12,641,778 shares. RIME last traded at $2.61 on September 29, 2025.
Algorhythm Holdings, Inc. (RIME) calls a virtual annual meeting on November 20, 2025 to vote on seven directors and several capital and governance proposals. The agenda includes: authorization for a reverse stock split at a ratio between 1-for-2 and 1-for-10, a reincorporation to Nevada, an amendment to the 2022 Equity Incentive Plan to raise authorized shares to 5,000,000, approval of potential share issuances to Streeterville Capital, LLC in pre-paid financings that may equal or exceed 20% of outstanding common stock, ratification of M&K CPAs as auditor, and potential adjournment.
Holders of record on September 29, 2025 may vote; 2,641,778 shares were outstanding as of the record date. For Proposal 5, 95,694 Streeterville “Commitment Shares” will be excluded from the Nasdaq-compliance tabulation. A quorum requires one-third of shares (33 1/3%). The reverse split is intended to help maintain Nasdaq’s $1.00 bid price standard, with implementation at the board’s discretion within one year of approval.